KHIRON: Enters First Latin American Cannabis Lines of Research Targeting U.S. $44 Billion Dermatological Drug Market
Clinical research partnership with Centro Dermatológico Federico Lleras Acosta (CDFLLA), focuses on effectiveness of medical cannabis for dermatological conditions defined in three main lines of research: Melanoma, Keratinocytes and Mycobacterial growth. Read More »